Entity Addresses, Address Type [Axis] Business Contact [Member] Components of equity [axis] Share Capital [Member] Share premium [member] Merger reserve [member] Warrant reserve [member] Foreign Exchange Reserve [Member] Retained earnings, profit (loss) for reporting period [member] Subsidiaries [axis] Biodexa Pharmaceuticals PLC [member] Biodexa Australia PTY Limited [member] Biodexa Limited [Member] Biodexa Ireland Limited [Member] Biodexa Pharmaceuticals (Wales) Limited [member] Biodexa US, Inc [Member] Haaland UK Limited [Member] PharMida AG [member] Classes of share capital [axis] Ordinary shares [member] ‘A’ deferred shares [member] ‘B’ deferred shares [member] ‘C’ deferred shares [member] ‘D’ deferred shares [Member] Categories of related parties [axis] FAP Projects [Member] Classes of intangible assets and goodwill [axis] Goodwill [member] Intangible assets under development [member] IT and website costs [member] Classes of property, plant and equipment [axis] Fixtures and fittings [member] Leasehold improvements [member] Computer equipment [member] Laboratory equipment [member] Right of use asset [member] Classes of assets [axis] MTX228 tolimidone acquired IPRD* [member] MTX230 eRapa acquired IPRD* [member] Geographical areas [axis] Belgium [Member] Major customers [axis] Customer A [member] Income Statement Location [Axis] Research and development [member] Administrative costs [member] General and administration [member] Title and Position [Axis] Director [Member] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Gross Carrying Amount [member] Right-of-use assets [member] Accumulated depreciation and amortisation [member] Land and buildings [member] Accumulated depreciation, amortisation and impairment [member] Biodexa Australia PTY Limited 1 [member] Biodexa Limited 1 [Member] Biodexa Pharmaceuticals Wales Limited Formerly Midatech Pharma Wales Limited [Member] Haaland UK Limited [member] PharMida AG 1 [Member] Liabilities arising from financing activities [axis] Long-term borrowings [member] Short-term borrowings [member] Biological assets [axis] Emtora [Member] Classes of financial instruments [axis] Promissory Note [Member] Finance Lease [member] Series L ADS warrants [Member] J ADS Warrants [member] Series K warrants [member] Series G ADS Warrants [member] Series H warrants [member] Series E ADS Warrants [member] Series F ADS Warrants [member] Series D ADS Warrants [member] Series ADS Warrants [member] Warrant one [member] Warrant two [member] Warrant three [member] Warrant four [member] Warrant five [member] Warrant seven [member] Warrant Seven [Member] DARA Warrants [member] DARA Options [member] Levels of fair value hierarchy [axis] Level 3 of fair value hierarchy [member] Valuation techniques used in fair value measurement [axis] Black-Scholes option pricing model [member] Black-Scholes option pricing model one [member] Black-Scholes option pricing model two [member] Black-Scholes option pricing model three [member] Black-Scholes option pricing model four [member] Black-Scholes option pricing model five [member] Black-Scholes option pricing model six [member] Black-Scholes option pricing model seven [member] Monte Carlo simulation model [member] Monte Carlo simulation model one [member] Types of risks [axis] Foreign exchange risk [member] Currency [Axis] United Kingdom, Pounds United States of America, Dollars Other Currency [Member] Foreign currency sensitivity analysis [member] Euro Member Countries, Euro Other [member] Liquidity risk [member] Maturity [axis] Not later than three months [member] Trade and other payables [member] Later than three months and not later than one year [member] Later than one year and not later than two years [member] Later than two years and not later than five years [member] Later than five years [member] Deferred considerations [member] Government and research loans [member] Pre-Funded warrants [Member] Merger Reserve [member] Reserve of exchange differences on translation [member] Retained earnings [member] Date Of Grant [Axis] Grant 1 [Member] Grant 2 [Member] Grant 3 [Member] Grant 4 [Member] Grant 5 [Member] Grant 6 [Member] Grant 7 [Member] Grant 8 [Member] Grant 9 [Member] Grant 10 [Member] Grant 11 [Member] Grant 12 [Member] Grant 13 [Member] Grant 14 [Member] Grant 15 [Member] Grant 16 [Member] Grant 17 [Member] Grant 18 [Member] Grant 19 [Member] Grant 20 [Member] Grant 21 [Member] Grant 22 [Member] Grant 23 [Member] Grant 24 [Member] Grant 25 [Member] Grant 26 [Member] Grant 27 [Member] Grant 28 [Member] Grant 29 [Member] Grant 30 [Member] Grant 31 [Member] Grant 32 [Member] Grant 33 [Member] Grant 34 [Member] Grant 35 [Member] Grant 36 [Member] Grant 37 [Member] Warrants Grant 1 [Member] Warrants Grant 2 [Member] Warrants Grant 3 [Member] Warrants Grant 4 [Member] Warrants Grant 5 [Member] Warrants Grant 6 [Member] Warrants [member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Name Auditor Location Profit or loss [abstract] Revenue Other income Research and development costs Administrative costs Loss from operations Finance income Finance expense Loss before tax Taxation Loss for the year attributable to the owners of the parent Other comprehensive income: Items that will or may be reclassified subsequently to profit or loss: Exchange gains arising on translation of foreign operations Total other comprehensive income net of tax Total comprehensive loss attributable to the owners of the parent Loss per share Continuing operations Basic loss perordinary share Diluted loss perordinary share Statement of financial position [abstract] Assets Non-current assets Property, plant and equipment Intangible assets  Total Non-Current Assets Current assets Trade and other receivables Current taxation receivable Cash and cash equivalents  Total Current Assets Total assets Liabilities Non-current liabilities Deferred consideration Borrowings  Total Non-Current Liabilities Current liabilities Trade and other payables Deferred consideration Borrowings Provisions Derivative financial liability  Total Current liabilities Total liabilities Issued capital and reserves attributable to owners of the parent Share capital Share premium Merger reserve Warrant reserve Foreign exchange reserve Accumulated deficit Total equity Total equity and liabilities Statement of cash flows [abstract] Cash flows from operating activities Loss for the year Adjustments for: Depreciation of property, plant and equipment Depreciation of right of use asset Amortisation of intangible fixed assets Loss on disposal of  property, plant and equipment Impairment of loan Impairment of ELOC upfront fee Finance income Finance expense Share-based payment charge Taxation Foreign exchange losses/(gains) Cash flows from operating activities before changes in working capital Decrease/(Increase) in trade and other receivables (Decrease)/Increase in trade and other payables (Decrease)/Increase in provisions Cash used in operations Taxes received Net cash used in operating activities Investing activities Purchases of property, plant and equipment Proceeds from disposal of fixed assets Purchase of intangible asset/deferred consideration Loan granted Interest received Net cash (used in)/generated from investing activities Financing activities Interest paid Amounts paid on lease liabilities (Repayment)/Proceeds from promissory note Share issues including warrants, net of costs Net cash generated from financing activities Net increase/(decrease) in cash and cash equivalents Cash and cash equivalents at beginning of year Exchange (losses)/gains on cash and cash equivalents Cash and cash equivalents at end of year Statement of changes in equity [table] IfrsStatementLineItems [Line Items] At 1 January 2023 Foreign exchange translation Total comprehensive loss Transactions with owners Shares issued on 22 May 2024 Costs associated with share issue on 22 May 2024 Shares issued on 22 July 2024 Costs associated with share issue on 22 July 2024 Exercise of warrants on 22 March 2022 Shares issued on 15 February 2023 Costs associated with share issue on 15 February 2023 Shares issued on 26 May 2023 Costs associated with share issue on 26 May 2023 Shares issued on 21 December 2023 Costs associated with share issue on 21 December 2023 Issue of shares to purchase intangible asset Shares issued under ELOC agreement Costs associated with ELOC agreement Shares issued on 15 May 2025 Costs associated with share issue on 15 May 2025 Shares issued 19 December 2025 Costs associated with share issue on 19 December 2025 Lapse warrants Share-based payment charge Total contribution by and distributions to owners At 31 December 2023 Notes and other explanatory information [abstract] Accounting policies Critical Accounting Estimates And Judgements Critical accounting estimates and judgements Revenue Loss from operations Staff Costs Staff costs Finance income and expense Taxation Loss Per Share Loss per share Property Plant And Equipment Property, plant and equipment Leases Leases Intangible Assets Intangible assets Subsidiaries Trade and other receivables Cash and cash equivalents and cash flow supporting notes Trade and other payables Deferred Consideration Deferred consideration Borrowings Provisions Provisions Derivative Financial Liability Current Derivative financial liability – current Financial instruments – risk management Deferred Tax Deferred tax Share capital Reserves Retirement Benefits Retirement benefits Share-based payments Capital Commitments Capital commitments Related party transactions Contingent liabilities Ultimate Controlling Party Ultimate controlling party Post Balance Sheet Events Post Balance Sheet Events Basis for consolidation Going concern – material uncertainty Revenue Accounting for rRapa and CPRIT grant Business combinations and externally acquired intangible assets Internally generated intangible assets (development costs) Impairment of non-financial assets Patents and trademarks Foreign currency Financial assets and liabilities Share capital Retirement benefits: defined contribution schemes Provisions Share-based payments Leases Taxation Deferred taxation Property, plant and equipment Schedule of entities Schedule of FAP project Schedule of intangibles assets useful economic lives Schedule of depreciation rates of property, plant and equipment Schedule of fair value of the asset Schedule of revenue by geographical analysis Schedule of performance obligations Schedule of commercial segment Schedule of loss from operations Schedule of staff costs Schedule for average number of employed staff Schedule of Management Personnel Compensation Schedule of emoluments disclosed Schedule of finance income Schedule of components of income tax expense Schedule of difference between actual tax charge and the standard rate of corporation tax Schedule of loss per share Schedule of detailed information about property, plant and equipment Schedule of market rental rates Low value leases expensed in year Schedule of reconciliation of changes in intangible assets and goodwill Schedule of condensed financial statements Schedule of subsidiaries Schedule of trade and other receivables Schedule of cash and cash equivalents Schedule of cash inflows from an equity financing transaction Schedule of changes in bank loan liabilities Schedule of trade and other payables Schedule of deferred consideration Schedule of borrowings Schedule of provisions Schedule of derivative financial liability Schedule of warrants outstanding Schedule of consolidated derivative financial instruments Schedule of consolidated financial assets and liabilities at fair value Schedule of foreign exchange risk Schedule of foreign currency exchange rates Schedule of contractual maturities of financial liabilities Schedule of unused tax losses carried forward Schedule of detailed information about share capital Schedule of warrant reserve recognize Schedule of ordinary and deferred shares Schedule of reserves Details of all share options granted under the schemes are set out below Schedule of fair value of options granted Schedule of warrants are accounted for as share based payments Schedule of fair value of warrants granted Disclosure of subsidiaries [table] Entity Summary description Disclosure of transactions between related parties [table] Prepayments Accrued revenue Deferred revenue Disclosure of reconciliation of changes in intangible assets and goodwill [table] Useful economic lives Disclosure of detailed information about property, plant and equipment [table] Description of useful life, property, plant and equipment Loss from operations Negative cash flows from operating activities Accumulated deficit Cash and cash equivalents Equity Line of Credit Equity Line of Credit undraw Share par value (in dollars per share) Disclosure of fair value measurement of assets [table] % change in fair value Carrying value of intangibles not yet ready for use Unutilised tax losses Disclosure of disaggregation of revenue from contracts with customers [table] Revenue Contractual assets, beginning Contractual liabilities, beginning Contractual assets, Transfers in the period from contract assets to trade receivables Contractual liabilities, Transfers in the period from contract assets to trade receivables Contractual assets, Amounts included in contract liabilities that was recognised as revenue during the period Contractual liabilities, Amounts included in contract liabilities that was recognised as revenue during the period Contractual assets, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period Contractual liabilities, Amounts included in contract liabilities that was recognised as grant income and netted against the relevant expenses in the period Contractual assets, Excess of revenue recognised over cash Contractual liabilities, Excess of revenue recognised over cash Contractual assets, Cash received in advance of performance and not recognised as revenue during the period Contractual liabilities, Cash received in advance of performance and not recognised as revenue during the period Contractual assets, Foreign exchange Contractual liabilities, Foreign exchange Contractual assets, ending Contractual liabilities, ending Disclosure of major customers [table] Percentage of revenue in excess of 10% IfrsStatementTable [Table] Depreciation of property, plant and equipment Depreciation of right of use asset Amortisation of intangible assets - software Impairment of financial asset Impairment of commission paid in advance on ELOC Provision against future loss on loan agreement Fees payable to the Company’s auditor for the audit of the parent Company financial statements Fees payable to the Company’s auditor for the audits of the subsidiary financial statements - Audit related services -  Audit -  Audit related services Foreign exchange (gain)/loss Loss on disposal of property, plant and equipment Equity settled share-based payment – employee schemes Wages and salaries Defined contribution pension cost (note 24) Social security contributions and similar taxes Staff costs gross Average number of staff employee Short term employee benefits Post-employment benefits Termination benefits Share-based payment Management Personnal Compensation Disclosure of information about key management personnel Finance income Interest received on bank deposits Other interest receivable Gain on equity settled derivative financial liability Total finance income Finance expense Interest expense on lease liabilities Interest expense on deferred consideration Other loans Total finance expense Current tax credit Current tax (charged)/credited to the income statement Adjustment in respect of prior year  Current tax credit Deferred tax credit Reversal of temporary differences Total tax credit Loss before tax Expected tax credit based on the standard rate of United Kingdom corporation tax at the domestic rate of 25% (2024: 25%; 2023: 25.52%) Expenses not deductible for tax purposes Income not taxable Adjustment in respect of prior period Effect of R&D relief Deferred tax not recognised Total tax credited to the income statement Numerator Loss used in basic EPS and diluted EPS: Continuing operations Denominator Weighted average number of ordinary shares used in basic EPS: Basic and diluted loss per share: Basic loss per share Diluted loss per share Description of stock split Balance at beginning Additions Transfer Disposals Balance at ending Balance at beginning Transfer Charge for the year Disposals Balance at ending Net book value Right of use asset At 1 January Interest expenses Lease payments At 31 December Low value leases expensed  Total Total cash outflow for leases Balance at beginning Acquisition Disposal Balance at end Balance at beginning Amortisation charge for the year Disposal Balance at end Net book value Carrying amount Name Registered office Nature of Operation Trade receivables Other receivables Total trade and other receivables Less: non-current portion Current portion Cash at bank available on demand Gross proceeds Transaction costs Proceeds from issuing shares Disclosure of reconciliation of liabilities arising from financing activities [table] Beginning Cash Flows Foreign Exchange Loans and borrowings classified as non-current 31 December 2024 becoming current in 2025 Deferred consideration on acquisition Promissory note issued Transfer to share premium on exercise of warrants Warrants issued Gain recognised in finance income within the consolidated statement of comprehensive income Interest accruing in period Ending Exercise of warrants - transfer to share premium Current Trade payables Other payables Accruals Total financial liabilities, excluding loans and borrowings, classified as financial liabilities measured at amortised cost Tax and social security Deferred revenue Total trade and other payables Opening provision at 1 January On acquisition of licence Payments Interest expense Foreign exchange Deferred consideration Less: non-current portion Current portion Disclosure of reconciliation of changes in biological assets [table] Quarterly payments Liability increase and decrease description Disclosure of detailed information about financial instruments [table] Current borriwings Non current borriwings Opening provision at beginning Utilisation of provision Provision recognised in the year Opening provision at ending Less: non-current portion Current portion Derivative Financial Liability - Current Balance at beginning Gain recognised in finance (income)/expense within the consolidated statement of comprehensive income Balance at ending Number of shares outstanding at beginning Lapsed Granted Exercised Number of shares outstanding at end Number of warrants issued Trade receivables Other receivables Total financial assets Accruals Borrowings Total financial liabilities – amortised cost Equity settled derivative financial liability Equity settled derivative financial liability Valuation technique (s) and key input(s) Significant unobservable input(s) Relationship of unobservable inputs to fair value Significant unobservable input(s) Relationship of unobservable inputs to fair value Significant unobservable input(s) Relationship of unobservable inputs to fair value Disclosure of risk management strategy related to hedge accounting [table] Loss before tax Total equity Total Proceeds from Equity Line of Credit Warrant Inducement Proceeds from registered offering Principle amount Proceeds from note Proceeds from warrants exercised Proceeds from private placement Gross losses Potential deferred tax asset Net deferred tax assets Description of deferred tax asset Number Total Beginning balance, shares December 2025 Registered Offering Exercised Lapsed Ending balance, shares Beginning balance, amount Private Placements Consideration for Private Placements Registered Direct Offering Consideration for Registered Direct Offering Share sub-division and re-designation Shares issued on purchase Intangible asset Consideration for Shares issued on purchase Intangible asset Registered Offering Consideration for Registered Offering Warrant inducement Consideration for shares issued on warrant inducement Exercise pre-funded warrants Consideration exercise pre-funded warrants Exercise Series E & Series F warrants Consideration exercise series E & series F warrants Shares issued under ELOC Consideration for Shares issued under ELOC Description of nature and purpose of reserves within equity Retirement benefits Grant date Beginning of the year Granted Lapsed Forfeited Ending of the year Exercise Price Options exercisable Weighted average exercise price of outstanding options Weighted average exercise price of options exercised Weighted average exercise price of options lapsed Weighted average exercise price of options forfeited Weighted average exercise price of options granted Weighted average remaining contractual life of outstanding options Number of options Option pricing models used Share price Exercise price of options issued in year Contractual life Expected life Volatility Expected dividend yield Risk free rate Warrants exercisable Number of ADS warrants granted Exercise price of warrants issued in year Aggregate consideration Requested for reimbursement Contingent liability The information of black scholes option pricing model. The amount represents other receivables. The amount of outstanding funds of the entity that is obligated to repay. The description of inputs used in the fair value measurement of assets. Inputs are the assumptions that market participants would use when pricing the asset, including assumptions about risk such as the risk inherent in a particular valuation technique used to measure fair value (such as a pricing model) and the risk inherent in the inputs to the valuation technique. The description of the reasons for the fair value measurement of assets. The description of inputs used in the fair value measurement of assets. Inputs are the assumptions that market participants would use when pricing the asset, including assumptions about risk such as the risk inherent in a particular valuation technique used to measure fair value (such as a pricing model) and the risk inherent in the inputs to the valuation technique. The description of the reasons for the fair value measurement of assets. The information of monte carlo simulation model. The member stands for montec carlos simultaion model. This member stands for information by currency. This member stands for entity owned or controlled by another entity. The member stands for IT and website costs. The member stands for laboratory equipment. The member stands for right of use of assets. This member stands for merger reserve. Represent information about the grant date. The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table. It represents as a weighted average exercise price of share options outstanding. It represents as a weighted average exercise price of share options forfeIted. It represents as a weighted average exercise price of share options granted. The weighted average remaining contractual life of outstanding share options. The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. The amount of excercise price of option issued in year. It represents as a contractual life term. It represents as a expected life term. The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table. This member stands for research and development. The amount of income or expense relating to fees and commissions. Represents other service amount. Represents other service amount. The cost paid to staff gross. This member stands for general and administrative. The amount of low value lease expense. The funds raised through public offering. The costs of funds raised through public offering. The amount of increase through loans and borrowings liabilities arising from financing activities. The amount of transfer to shares premium on excercise of warrants. The amount represent of warrants issued. The amount of increase through interest accruing in period liabilities arising from financing activities. This member stands for finance lease. Represnts amount repreesnts provision. The amount of gains from equity settled derivative financial liability. This member stands for foreign currency sensitivity analysis.= This member stands for information by currency. This member stands for trade and other payables. This member stands for government and research loans. The information of deferred tax asset. Number of stock issued for consideration during the period. Research and development expense Administrative expenses Profit (loss) from operating activities Profit (loss) before tax Tax expense (income) Other comprehensive income Non-current assets [Default Label] Current assets [Default Label] Assets [Default Label] Non-current liabilities [Default Label] Borrowings [Default Label] Current liabilities [Default Label] Liabilities [Default Label] Equity and liabilities Adjustments for gain (loss) on disposals, property, plant and equipment Adjustments to reconcile profit (loss) Cash flows from (used in) operations Income taxes paid (refund), classified as operating activities Cash flows from (used in) operating activities Purchase of property, plant and equipment, classified as investing activities PurchaseOfIntangibleAssetdeferredConsideration LoanGranted Cash flows from (used in) investing activities Interest paid, classified as financing activities Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents after effect of exchange rate changes Increase (decrease) through share-based payment transactions, equity Disclosure of revenue [text block] Disclosure of income tax [text block] DisclosureOfEarningsPerSharesExplanatory DisclosureOfPropertyPlantAndEquipmentsExplanatory DisclosureOfLeaseExplanatory DisclosureOfIntangibleAssetExplanatory Disclosure of trade and other receivables [text block] Disclosure of trade and other payables [text block] DeferredConsiderationTextBlock Disclosure of borrowings [text block] ProvisionsTextBlock Disclosure of issued capital [text block] DisclosurePostBalanceSheetEventsTextBlock Description of accounting policy for recognition of revenue [text block] Description of accounting policy for issued capital [text block] Description of accounting policy for provisions [text block] Description of accounting policy for share-based payment transactions [text block] Description of accounting policy for leases [text block] DescriptionOfAccountingPolicyTextBlock Description of accounting policy for property, plant and equipment [text block] LossFromOperations AccumulatedDeficit Cash SalesRevenue Contract assets Contract liabilities DepreciationOfPropertyPlantAndEquipment DepreciationOfRightOfUseAsset Deferred tax expense (income) relating to origination and reversal of temporary differences AdjustmentsToBroughtForwardValues Profit (loss) from continuing operations AccumulatedDepreciationAndAmortisation IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment1 Disposals [Default Label] Lease liabilities AccumulatedAmortisationAndImpairment Disposal [Default Label] Trade and other receivables [Default Label] Other non-current receivables Liabilities arising from financing activities Current financial liabilities DeferredIncome1 Trade and other payables [Default Label] DeferredConsideration Provision Warrants Current trade receivables OtherReceivables1 Accruals [Default Label] Borrowings1 DescriptionOfInputsUsedInFairValueMeasurementAssets1 DescriptionOfReasonsForFairValueMeasurementAssets1 DescriptionOfInputsUsedInFairValueMeasurementAssets2 DescriptionOfReasonsForFairValueMeasurementAssets2 ValueOfShares NumberOfShareIssuedForConsideration Exercised [Default Label] Lapsed [Default Label] ValueOfSharesIssued RetirementBenefits Number of share options outstanding in share-based payment arrangement Number of share options expired in share-based payment arrangement